Pages that link to "Q36182053"
Jump to navigation
Jump to search
The following pages link to The human genome project and novel aspects of cytochrome P450 research (Q36182053):
Displaying 36 items.
- Current issues in organophosphate toxicology (Q22337366) (← links)
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions (Q24643366) (← links)
- Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy (Q27022665) (← links)
- Drug cocktail optimization in chemotherapy of cancer (Q28484254) (← links)
- Detection of CYP2C19 Genetic Variants in Malaysian Orang Asli from Massively Parallel Sequencing Data (Q28553076) (← links)
- A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs (Q33552774) (← links)
- Drug-gene interactions: inherent variability in drug maintenance dose requirements (Q34154939) (← links)
- Clinically Relevant Genetic Variations in Drug Metabolizing Enzymes (Q35032378) (← links)
- CYP2D6 polymorphisms in patients with porphyrias (Q35586929) (← links)
- A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1. (Q35671222) (← links)
- The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response (Q36239112) (← links)
- Functional characterization of cytochrome P450 monooxygenases in the cereal head blight fungus Fusarium graminearum. (Q36308715) (← links)
- Copy number variants and pharmacogenomics (Q36341735) (← links)
- Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications (Q36874393) (← links)
- Characterization of orphan human cytochromes P450. (Q36929625) (← links)
- Molecular mechanisms underlying chemical liver injury (Q36991523) (← links)
- Predicting the clinical relevance of drug interactions from pre-approval studies. (Q37610142) (← links)
- Psychophysiological stress: a significant parameter in drug pharmacokinetics (Q38120048) (← links)
- Diet and our genetic legacy in the recent anthropocene: a Darwinian perspective to nutritional health. (Q38197486) (← links)
- Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction (Q38683483) (← links)
- Patient preferences for pharmacogenetic screening in depression (Q39324637) (← links)
- Evidence for polymorphism in the cytochrome P450 2D50 gene in horses. (Q40461522) (← links)
- Cytochrome P450s and cytochrome P450 reductase in the olfactory organ of the cotton leafworm Spodoptera littoralis (Q42011544) (← links)
- π-π Stacking mediated drug-drug interactions in human CYP2E1. (Q44774734) (← links)
- Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease (Q45151001) (← links)
- Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population (Q45265157) (← links)
- Prevalence of CYP2C9 polymorphisms in the south of Europe. (Q46043535) (← links)
- Zederone, a sesquiterpene from Curcuma elata Roxb, is hepatotoxic in mice (Q46845564) (← links)
- Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery (Q50179674) (← links)
- Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services? (Q51818173) (← links)
- Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients. (Q54435691) (← links)
- Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways. (Q54516740) (← links)
- An update on metabolism studies using human hepatocytes in primary culture (Q58680978) (← links)
- Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids (Q85048638) (← links)
- Is calcifediol better than cholecalciferol for vitamin D supplementation? (Q88527650) (← links)
- Optimising migraine treatment: from drug-drug interactions to personalized medicine (Q92119375) (← links)